AU775713B2 - Potassium channel interactors and uses therefor - Google Patents
Potassium channel interactors and uses therefor Download PDFInfo
- Publication number
- AU775713B2 AU775713B2 AU14797/00A AU1479700A AU775713B2 AU 775713 B2 AU775713 B2 AU 775713B2 AU 14797/00 A AU14797/00 A AU 14797/00A AU 1479700 A AU1479700 A AU 1479700A AU 775713 B2 AU775713 B2 AU 775713B2
- Authority
- AU
- Australia
- Prior art keywords
- seq
- pcip
- nucleic acid
- polypeptide
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10933398P | 1998-11-20 | 1998-11-20 | |
US60/109333 | 1998-11-20 | ||
US11003398P | 1998-11-25 | 1998-11-25 | |
US60/110033 | 1998-11-25 | ||
US11027798P | 1998-11-30 | 1998-11-30 | |
US60/110277 | 1998-11-30 | ||
US09/298731 | 1999-04-23 | ||
US09/298,731 US6369197B1 (en) | 1998-11-20 | 1999-04-23 | Potassium channel interactors and uses therefor |
US09/350,874 US20020019020A1 (en) | 1998-11-20 | 1999-07-09 | Methods for treating cardiovascular disorders |
US09/350874 | 1999-07-09 | ||
US09/350,614 US6689581B1 (en) | 1998-11-20 | 1999-07-09 | Potassium channel interactors and uses therefor |
US09/350614 | 1999-07-09 | ||
US09/399913 | 1999-09-21 | ||
US09/400492 | 1999-09-21 | ||
US09/400,492 US7115381B1 (en) | 1998-11-20 | 1999-09-21 | Methods for treating cardiovascular disorders |
US09/399,913 US6361971B1 (en) | 1998-11-20 | 1999-09-21 | Nucleic acid molecules encoding potassium channel interactors and uses therefor |
PCT/US1999/027428 WO2000031133A2 (fr) | 1998-11-20 | 1999-11-19 | Proteines d'interaction de canaux potassiques (pcip) et procedes de leur utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1479700A AU1479700A (en) | 2000-06-13 |
AU775713B2 true AU775713B2 (en) | 2004-08-12 |
Family
ID=27574798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU14797/00A Ceased AU775713B2 (en) | 1998-11-20 | 1999-11-19 | Potassium channel interactors and uses therefor |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1131349A2 (fr) |
JP (1) | JP2002530104A (fr) |
CN (1) | CN1346368A (fr) |
AU (1) | AU775713B2 (fr) |
BR (1) | BR9915513A (fr) |
CA (1) | CA2351365A1 (fr) |
CZ (1) | CZ20011764A3 (fr) |
IL (1) | IL143148A0 (fr) |
MX (1) | MXPA01004903A (fr) |
NO (1) | NO20012471L (fr) |
NZ (1) | NZ512332A (fr) |
WO (1) | WO2000031133A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6369197B1 (en) | 1998-11-20 | 2002-04-09 | Millennium Pharmaceuticals, Inc. | Potassium channel interactors and uses therefor |
US7078481B1 (en) | 1998-11-20 | 2006-07-18 | Wyeth | Potassium channel interactors and uses therefor |
BR0114383A (pt) * | 2000-09-27 | 2005-04-12 | Millennium Pharm Inc | Interatuadores de canais de potássio e aplicações dos mesmos |
EP2353014A2 (fr) * | 2008-11-06 | 2011-08-10 | Basf Se | Test de criblage ea pour insecticides |
GB201906482D0 (en) * | 2019-05-08 | 2019-06-19 | Evox Therapeutics Ltd | Exosome comprising stabilized RNA therapeutics |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4758997A (en) * | 1996-10-17 | 1998-05-11 | Nps Pharmaceuticals, Inc. | Potassium channel blocking compounds and their use |
US6117989A (en) * | 1998-03-26 | 2000-09-12 | Incyte Pharmaceuticals, Inc. | Human calcium-binding proteins |
-
1999
- 1999-11-19 MX MXPA01004903A patent/MXPA01004903A/es unknown
- 1999-11-19 BR BR9915513-3A patent/BR9915513A/pt not_active IP Right Cessation
- 1999-11-19 AU AU14797/00A patent/AU775713B2/en not_active Ceased
- 1999-11-19 CZ CZ20011764A patent/CZ20011764A3/cs unknown
- 1999-11-19 EP EP99972644A patent/EP1131349A2/fr not_active Withdrawn
- 1999-11-19 WO PCT/US1999/027428 patent/WO2000031133A2/fr not_active Application Discontinuation
- 1999-11-19 JP JP2000583959A patent/JP2002530104A/ja not_active Withdrawn
- 1999-11-19 IL IL14314899A patent/IL143148A0/xx unknown
- 1999-11-19 CN CN99815642A patent/CN1346368A/zh active Pending
- 1999-11-19 NZ NZ512332A patent/NZ512332A/xx unknown
- 1999-11-19 CA CA002351365A patent/CA2351365A1/fr not_active Abandoned
-
2001
- 2001-05-18 NO NO20012471A patent/NO20012471L/no not_active Application Discontinuation
Non-Patent Citations (2)
Title |
---|
DATABASE EMBL (ONLINE) ID:A 1038858, 1 JULY 1998 * |
NATURE MEDICINE, VOL.4 NO.10, OCTOBER 1998, PP 1177-1181 * |
Also Published As
Publication number | Publication date |
---|---|
CN1346368A (zh) | 2002-04-24 |
MXPA01004903A (es) | 2003-03-10 |
IL143148A0 (en) | 2002-04-21 |
NO20012471L (no) | 2001-07-18 |
EP1131349A2 (fr) | 2001-09-12 |
WO2000031133A2 (fr) | 2000-06-02 |
WO2000031133A3 (fr) | 2000-10-05 |
JP2002530104A (ja) | 2002-09-17 |
CA2351365A1 (fr) | 2000-06-02 |
BR9915513A (pt) | 2002-02-05 |
NO20012471D0 (no) | 2001-05-18 |
NZ512332A (en) | 2004-02-27 |
CZ20011764A3 (cs) | 2002-01-16 |
AU1479700A (en) | 2000-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020168708A1 (en) | Muscarinic receptors and uses therefor | |
US20030232378A1 (en) | Novel toll molecules and uses therefor | |
US6780987B1 (en) | β-cap73 control of normal and abnormal cell migration | |
US6518398B1 (en) | ERG potassium channel | |
JP2004507215A (ja) | 新規のp−セレクチン糖タンパク質リガンド(psgl−1)結合タンパク質およびその使用 | |
AU775713B2 (en) | Potassium channel interactors and uses therefor | |
US6225085B1 (en) | LRSG protein and nucleic acid molecules and uses therefor | |
US6361971B1 (en) | Nucleic acid molecules encoding potassium channel interactors and uses therefor | |
US6689581B1 (en) | Potassium channel interactors and uses therefor | |
US20020197680A1 (en) | 54420, a novel human calcium channel | |
AU2001296393A1 (en) | Potassium channel interactors and uses therefor | |
US20020081658A1 (en) | 18610, a novel human transient receptor and uses thereof | |
US7078481B1 (en) | Potassium channel interactors and uses therefor | |
US6756212B1 (en) | Isolated proteins and nucleic acid molecules having homology to the NIP2 protein and uses thereof | |
US20020034781A1 (en) | 12303, a novel human TWIK molecule and uses thereof | |
US7439029B2 (en) | Human 9q polypeptides method | |
US20020081651A1 (en) | 26649, a novel human GTPase activating molecule and uses therefor | |
WO2000043514A9 (fr) | Canal ionique detectant les acides et ses utilisations | |
US20020019020A1 (en) | Methods for treating cardiovascular disorders | |
ZA200103995B (en) | Potassium channel interactors and uses therefor. | |
US20030049727A1 (en) | 25658, a novel human calcium channel subunit and uses thereof | |
WO2001081416A2 (fr) | Le 47615, nouveau canal ionique humain et ses utilisations |